New - European Medical Journal

Continue

News

EMJ
Oncology
16 Dec 2014

New Oncotype DX® Data Presented at 2014 San Antonio Breast Cancer Symposium Further Demonstrate the Practice-Changing Impact of the Test in Guiding the Treatment of Early Stage Breast Cancer

GENEVA, Switzerland, [December 15, 2014] – Genomic Health announced presentation of the first prospective outcomes data from a large adjuvant study…
EMJ
Oncology
11 Dec 2014

Gilead Presents Follow-Up Data from Idelalisib (Zydelig®) Registrational Studies in Patients with Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma

San Francisco, December 10, 2014 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced long-term follow-up results from the registration studies…
EMJ
General Healthcare
2 Dec 2014

UEG Puts the Need for Better Care for IBD Patients in Europe on the Political Agenda

(Vienna, 02, December, 2014) With inflammatory bowel disease (IBD) thought to cost the European Community over €2 billion in annual healthcare costs…
EMJ
Hepatology
25 Nov 2014

Experts Call for Greater Awareness of Alcohol Related Liver Disease and Liver Cancer

Vienna, 24 November 2014 – United European Gastroenterology (UEG) is supporting the second annual Awareness Week on Alcohol Related Harm (AWARH)
EMJ
Oncology
24 Nov 2014

High-Dose Interleukin-2 Effective in Metastatic Renal Cell Cancer Pre-Treated with VEGF-Targeted Therapies

Lugano/Geneva, Switzerland, 24 November 2014 – High-dose interleukin-2 can be effective in selected metastatic renal cell cancer patients pre-treated…
EMJ
Oncology
21 Nov 2014

Immune Checkpoint Inhibitors May Work in Brain Cancers

LUGANO/GENEVA, Switzerland, 21 November 2014 – New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented…
EMJ
General Healthcare
21 Nov 2014

Possibilities for Personalised Vaccines Revealed at ESMO Symposium

LUGANO/GENEVA, Switzerland, 21 November 2014 – The possibilities for personalised vaccines in all types of cancer are revealed today in a lecture from…
EMJ
General Healthcare
6 Oct 2014

The Oncotype DX® Test and Precision Oncology: New Data Presented at ESMO Further Demonstrate Genomic Health’s Successful Approach to Understanding Tumour Biology

GENEVA, Switzerland, [September 29, 2014] — In line with this year’s theme for the annual European Society for Medical Oncology (ESMO) Congress…